Articles related to Clinical Pharmacology

An estimated 5% of U.S. adults have consumed at least one potentially hepatotoxic herbal supplement in the past month, raising concerns about liver health risks associated with unregulated botanical products.

CBD gummies offer a convenient administration method with prolonged effects, but their delayed onset presents unique considerations for therapeutic use. Understanding the pharmacokinetics and individual factors affecting CBD absorption is essential for optimizing patient outcomes.

In a phase 3 trial involving 5,338 cisgender women in South Africa and Uganda, twice-yearly lenacapavir injections demonstrated complete prevention of HIV infection, significantly outperforming daily oral medication regimens.

Blood thinners interact with various medications and supplements, potentially increasing bleeding risk or reducing efficacy. Physicians should be aware of these interactions and educate patients on the importance of consulting healthcare professionals before taking new products.

The 2022 ACIP recommendations introduce new pneumococcal conjugate vaccines and simplified dosing schedules, aiming to enhance prevention of invasive pneumococcal disease while improving guideline implementation in clinical practice.

A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.